385 related articles for article (PubMed ID: 28729433)
1. Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.
Kamikubo Y; Mendolicchio GL; Zampolli A; Marchese P; Rothmeier AS; Orje JN; Gale AJ; Krishnaswamy S; Gruber A; Østergaard H; Petersen LC; Ruf W; Ruggeri ZM
Blood; 2017 Oct; 130(14):1661-1670. PubMed ID: 28729433
[TBL] [Abstract][Full Text] [Related]
2. Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation.
Furukawa S; Nogami K; Ogiwara K; Shima M
Int J Hematol; 2019 Apr; 109(4):390-401. PubMed ID: 30756344
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs.
Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M
J Thromb Haemost; 2014 Nov; 12(11):1826-37. PubMed ID: 25163770
[TBL] [Abstract][Full Text] [Related]
4. Effects of anti-factor VIII inhibitor antibodies on factor VIIa/tissue factor-catalysed activation and inactivation of factor VIII.
Yada K; Nogami K; Ogiwara K; Shibata M; Shima M
Thromb Haemost; 2011 Jun; 105(6):989-98. PubMed ID: 21437361
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa.
Ollivier V; Chabbat J; Herbert JM; Hakim J; de Prost D
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1374-81. PubMed ID: 10807756
[TBL] [Abstract][Full Text] [Related]
6. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor.
van 't Veer C; Hackeng TM; Delahaye C; Sixma JJ; Bouma BN
Blood; 1994 Aug; 84(4):1132-42. PubMed ID: 8049429
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of factor VIIa-catalyzed activation of factor VIII.
Soeda T; Nogami K; Matsumoto T; Ogiwara K; Shima M
J Thromb Haemost; 2010 Nov; 8(11):2494-503. PubMed ID: 20735721
[TBL] [Abstract][Full Text] [Related]
8. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
Hoffman M; Monroe DM
Dis Mon; 2003 Jan; 49(1):14-21. PubMed ID: 12525825
[TBL] [Abstract][Full Text] [Related]
9. Synergy Between Tissue Factor and Exogenous Factor XIa in Initiating Coagulation.
Leiderman K; Chang WC; Ovanesov M; Fogelson AL
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2334-2345. PubMed ID: 27789475
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α.
Thomassen MC; Heinzmann AC; Herfs L; Hartmann R; Dockal M; Scheiflinger F; Hackeng TM; Rosing J
J Thromb Haemost; 2015 Jan; 13(1):92-100. PubMed ID: 25348176
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
Camerer E; Huang W; Coughlin SR
Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
[TBL] [Abstract][Full Text] [Related]
12. Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficiencies.
Slatter DA; Percy CL; Allen-Redpath K; Gajsiewicz JM; Brooks NJ; Clayton A; Tyrrell VJ; Rosas M; Lauder SN; Watson A; Dul M; Garcia-Diaz Y; Aldrovandi M; Heurich M; Hall J; Morrissey JH; Lacroix-Desmazes S; Delignat S; Jenkins PV; Collins PW; O'Donnell VB
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563336
[TBL] [Abstract][Full Text] [Related]
13. Factor VIII activation by factor VIIa analog (V158D/E296V/M298Q) in tissue factor-independent mechanisms.
Ogiwara K; Nogami K; Shima M
Thromb Haemost; 2011 Oct; 106(4):665-74. PubMed ID: 21901232
[TBL] [Abstract][Full Text] [Related]
14. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II.
van 't Veer C; Mann KG
J Biol Chem; 1997 Feb; 272(7):4367-77. PubMed ID: 9020158
[TBL] [Abstract][Full Text] [Related]
15. A cell-based model of thrombin generation.
Roberts HR; Hoffman M; Monroe DM
Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():32-8. PubMed ID: 16673264
[TBL] [Abstract][Full Text] [Related]
16. New insights into how blood clots: implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy.
Bajaj SP; Joist JH
Semin Thromb Hemost; 1999; 25(4):407-18. PubMed ID: 10548073
[TBL] [Abstract][Full Text] [Related]
17. Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor.
Waters EK; Genga RM; Schwartz MC; Nelson JA; Schaub RG; Olson KA; Kurz JC; McGinness KE
Blood; 2011 May; 117(20):5514-22. PubMed ID: 21389323
[TBL] [Abstract][Full Text] [Related]
18. Maturation of coagulation factor IX during Xase formation as deduced using factor VIII-derived peptides.
Fang H; Zögg T; Brandstetter H
FEBS Open Bio; 2019 Aug; 9(8):1370-1378. PubMed ID: 31077577
[TBL] [Abstract][Full Text] [Related]
19. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
Norledge BV; Petrovan RJ; Ruf W; Olson AJ
Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases.
Butenas S; van 't Veer C; Mann KG
J Biol Chem; 1997 Aug; 272(34):21527-33. PubMed ID: 9261172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]